Cytel -Model Solara -Clinical Trial Strategy Platform
Solara® is the first-to-market clinical trial strategy platform for simulation-guided clinical study design and selection. Using Solara, product development team explore thousands of new and varied design options, carefully pressure-test designs across a range of potential scenarios, and quantify tradeoffs to manage uncertainty, minimize costs, and accelerate speed to market.
- Reduce trial cost and/or duration by 10 – 20% on average
- Maximize probability of technical success
- Visualize risk scenarios and build your strategy
- Answer risk-based questions within minutes to improve strategic discussions
Solara’s user-friendly interface and dynamic visualizations create a digital workbench that simplifies collaboration and communication between biostatistics, medical, clinical operations, governance, and other disciplines. Teams can analyze simulated models to evaluate projected design performance, identify risks, optimize across multiple parameters, and adjust prioritization weighting to filter and match designs to organizational priorities in real time.
- Explore thousands of trial design options with variations across parameters including sample size, number of events, timing of interim analyses and more
- Pressure test design options against various scenarios such as low patient recruitment, endpoint selection, choice of target populations, and weak or delayed treatment effect
- Assess and quantify tradeoffs to align priorities and make critical decisions with confidence